Trial Profile
A cross-sectional trial to assess tocilizumab in patients with rheumatoid arthritis, idiopathic juvenile arthritis, and adult-onset still disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Jul 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Adult-onset Still's disease; Juvenile rheumatoid arthritis; Rheumatoid arthritis
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 31 Jul 2015 New trial record
- 10 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.